跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
S-Foxime - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
S-Foxime
Approved
STANDARD
S-Foxime
Brawn Laboratories Limited.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
769e5985d86756ed
Company
Brawn Laboratories Limited.
Type
Standard
Approval Details
Approval Id
769e5985d86756ed
Drug Approval Philippines Name
S-Foxime
Product Name
S-Foxime
Registration Number
DRP-6164-01
Brand Name
S-Foxime
Generic Name
Cefpodoxime (as proxetil)
Dosage Form
Film-Coated Tablet
Dosage Strength
200 mg
Manufacturer
Brawn Laboratories Limited.
Importer
Ambica International Trading Corp
Distributor
Starpharm, Inc.
Issuance Date
25 July 2024
Expiry Date
22 May 2030
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
769e5985d86756ed
Type
Standard
Back to Philippines FDA Approvals